Blog Header

In: in vitro

28 Apr, 2021Tech Snapshot® – Targeting Neuroinflammation to Combat Neurodegenerative and Rare Diseases


Tech Snapshot® captures today’s cutting-edge tools and technologies that will help drive drug discovery tomorrow. This installment was written by QPS, a global leader in clinical and preclinical research.

Read More

14 Dec, 2020Tech Snapshot® – Early-Development Assessment Tools: De-Risking Strategies For Biologics


Tech Snapshot® captures today’s cutting-edge tools and technologies that will help drive drug discovery tomorrow. This installment was written by Yvette Stallwood, Ph.D., Head of Applied Protein Services, Lonza Biologics.

Read More

19 Jun, 2019The Effects of Sex Bias in Preclinical Research and How it Can Be Changed


Upsetting the status quo is never easy, especially when it comes to scientific research. Just ask AstraZeneca duo Natasha A. Karp, Associate Principal Scientist/ Biostatistician and Neil Reavey, Associate Director, Research Assurance, who explore ways of overcoming the issue of sex bias in a paper entitled, “Sex Bias in Preclinical Research and Exploration of How to Change the Status Quo.”

Read More

11 Jul, 2013In Vitro Oncology versus In Vivo Models


As previously discussed, there is great value in using in vivo models such as genetically modified mice and xenograft models for oncology research. However…

Read More